Skip to NavigationSkip to content

Oxford Immunotec to supply TB diagnostic tests to china to aid in coronavirus crisis

Published on 23/01/20 at 12:18pm

As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the first case occurring in US borders, Oxford Immunotec Global has announced its plan to supply tuberculosis diagnostic tests to mainland China in an attempt to aid in identifying cases of the mysterious new disease.

The company’s T-SPOT test is to be donated on a scale valued at CNY 3,000,000 in order to coincide with World Tuberculosis Day, delivered to hospitals throughout China.

As a respiratory disease, the Wuhan coronavirus displays symptoms which can be easily mistaken for other respiratory conditions, including a sore throat, dry cough, fatigue and fever. If TB can be discounted from the equation early, it is hoped that patient diagnosis and outcomes can be improved.

The T-SPOT test has been approved in China since 2010, with the company saying it had become “a critical aid in the diagnosis of TB infection” in the country.

Professor Mou Xiangdong, Director of Respiratory and Critical Care Department, Beijing Tsinghua Chang Gung Hospital, commented on the plan: “We would like to thank Oxford Immunotec for their commitment to the Chinese people. As symptoms of some infections may be similar to TB, this test will help us differentiate these illnesses with greater accuracy during epidemic seasons.”

Matt Fellows

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches